Deloitte Corporate Finance

Loading ...
Jack Berlin
Business & Economics
Business News
<p>Healthcare Coverage Overview
Deloitte Corporate Finance LLC
April 2015
- 2 -
© 2015. For information, contact Deloitte Development LLC. 
About Deloitte: Leading Global and U.S. Advisor
* Deloitte Corporate Finance LLC, member FINRA, is a wholly-owned subsidiary of Deloitte Financial Advisory Services LLP. Investment banking products and services within the United States are offered 
exclusively through DCF.
DCF operates within one of the world’s leading professional services organizations, Deloitte Touche 
Tohmatsu Limited (“DTTL”), which offers broad-based advisory services with an integrated approach to 
leading organizations around the world.
Deloitte Touche Tohmatsu Limited
2014 Global Revenue: $34 Billion
210,000+ employees
Deloitte & Touche LLP
Deloitte Consulting LLP
Deloitte Financial
Advisory Services LLP
Deloitte Tax LLP
Deloitte Corporate Finance LLC*
Other FAS Services
 Global access and execution capabilities – A global network of more than 2,400 
corporate finance professionals with offices in over 60 countries providing clients with 
access to regional market insights and intelligence around the world.

Integrated transaction solutions – Together with member firms, provider of 
collaborative execution capabilities addressing the range of transactions and related 
financial, operational, human capital, information technology, tax and accounting issues.
 Strong reputation – Brand known for integrity and credibility across the globe helping 
increase opportunities for our clients.
 Knowledge and experience – Seasoned professionals with practical knowledge of the 
industry, actively involved through the entire deal process to drive transaction timing 
and value.
 Deloitte CRG
 Business Valuation
 Real Estate Consulting
 Engineering and 
Construction Consulting
 Deloitte Forensic
 Deloitte Analytics
- 3 -
© 2015. For information, contact Deloitte Development LLC. 
About Deloitte Corporate Finance LLC
DCF is a leading M&A advisor with global execution capabilities that leverages deep transaction experience 
to deliver innovative services and superior results to clients operating across eight core industry groups.
Nationwide Coverage with Global Access and Reach
The DCF Difference
Worldwide: 2,400 professionals across 60 countries
United States: 135 professionals based in 8 cities
Atlanta
Charlotte
Chicago
Dallas
Detroit
Houston
Los Angeles
New York
Comprehensive Service Offerings
Outstanding Reputation
Deep Industry Insight
 Sellside and Divestiture
 Buyside
 Capital Raising and Advisory
 Corporate and Board Advisory
 Employee Stock Ownership Plan 
(ESOP)
 Combined with member firms of 
Deloitte Touche Tohmatsu Limited, 
serves 79 percent of the
Fortune Global 500®.
 Ranked as the No. 3 global middle-
market financial advisor in 2014.(1)
Aerospace &
Defense
Financial
Services
Business
Services
General
Industrials
Consumer &
Retail
Healthcare &
Life Sciences
Energy &
Resources
Technology, 
Media & Telecom
Middle Market Focus
Low
B
re
ad
th
 o
f I
nd
us
tr
y 
&
 In
te
rn
at
io
na
l A
cc
es
s
High
High
Low
Boutique 
Banks
Bulge Bracket 
Banks
Footnote:
(1) Thomson Financial, 12 months ending 12/31/14.
© 2015. For information, contact Deloitte Development LLC. 
- 4 -
 DCF’s broad offering of services and highly-relevant transaction experience allows us to provide our clients with an 
objective perspective on shareholder alternatives.
DCF Service Offering
DCF Investment Banking Services
Sales and
Divestitures
Acquisition, 
Joint Venture 
and Alliance
Capital
Advisory
Capital 
Raising
Corporate 
Development 
Advisory
Board 
Advisory
 Pre-sale due 
diligence

Identify buyers
 Prepare 
confidential 
memorandum
 Clear the 
market
 Deal 
negotiation
 Coordinate 
closing
 Define 
acquisition 
goals
 Target 
evaluation
 Transaction 
modeling
 Finance 
assistance
 Deal 
negotiation
 Coordinate 
closing
 Refinancings
 Acquisitions, 
project 
financings, 
disposals, and 
mergers
 Restructurings
 General 
financial 
advisory
 Assess 
alternative 
structures
 Create a plan

Identify 
appropriate 
sources
 Transaction 
modeling
 Deal 
negotiation
 Coordinate 
closing
 Strategic 
options
 Buyer/Target 
search
 Complex 
financial 
modeling
 Full 
transaction 
execution 
support
 Fairness 
opinions
 Prioritize 
shareholder 
objectives
 Special 
committee 
financial 
advisory
 Strategic 
alternatives
M&A Services
Tax Services
(Deloitte Tax LLP)
(Deloitte Consulting LLP)
M&A Strategy and Post Merger 
Integration Services
(Deloitte Consulting LLP)
M&A Transaction Services
(Deloitte & Touche LLP)
(Deloitte Tax LLP)
© 2015. For information, contact Deloitte Development LLC. 
- 5 -
Deloitte Life Sciences & Healthcare Expertise
Life Sciences & Healthcare Industry Expertise
Example M&A Market Recognition
Forrester Research

“Deloitte provides a highly compelling mergers and 
acquisitions (M&A) services proposition through its 
broad portfolio and business expertise, underpinned 
by a consistent and integrated go-to-market strategy.”

“Deloitte provides an M&A services portfolio of 
compelling global breadth and global reach.”

“Clients value Deloitte’s customer-focused and 
flexible service model with strong M&A capabilities 
and thorough understanding of complex functional 
processes.”
Ambulatory Surgery Centers
Contract Manufacturers
Disease Management
Healthcare Information Technology
Healthcare Services
Laboratory Services
Life Sciences
Managed Care
Medical Information Services
Medical Supplies and Distribution
Pharmacy Benefit Management
Physician Practice Management
Specialty Pharmacies
Transcription, Billing, and Coding
Urgent Care Centers
DCF provides client-centered M&A advisory and execution services across a wide breadth of verticals within the life 
sciences and healthcare industry.
© 2015. For information, contact Deloitte Development LLC. 
- 6 -
Deloitte Life Sciences & Healthcare Qualifications 
 Deloitte has 9,400 professionals in the United States that offer healthcare industry services and solutions across 
strategy, operations, technology and human capital, tax, risk, security and privacy, and financial advisory.
 Deloitte’s Life Sciences and Healthcare Practice serves more than 95% of the Fortune 500® life sciences and 
healthcare companies, as well as the following:
– More than 90% of the Honor Roll Hospitals (as ranked by U.S. News & World Report)
–
9 of the 10 Largest Healthcare Systems (as ranked by Modern Healthcare)
–
9 of the 10 Largest For-Profit Healthcare Systems (as ranked by Modern Healthcare)
–
The Majority of the Largest Secular Not-for-Profit Healthcare Systems (as ranked by Modern Healthcare)
– More than 80% of the Best Children's Hospitals (as ranked by U.S. News & World Report)
Physicians and Healthcare Systems
Managed Care and Pharmacy Benefits Managers
– Nearly 85% of the Top 25 U.S. Health Plans (as ranked by AIS's Directory of Health Plans)
– Nearly 60% of the Nation's Blue Cross Blue Shield Plans
– More than 75% of the Top 25 Managed Care Organizations (as ranked by HealthLeaders)
–
6 of the Top 10 Pharmacy Benefits Managers (as ranked by Pharmacy Benefit Management Institute)
Pharmaceutical Manufacturers and Biotechnology Companies
– Nearly 90% of the 15 Largest Pharmaceutical Manufacturers (as ranked by Med Ad News)
–
6 of the 10 Largest Biotechnology Companies (as ranked by Med Ad News)
–
9 of the Top 10 Medical Device Manufacturers (as ranked by Medical Product Outsourcing)
© 2015. For information, contact Deloitte Development LLC. 
- 7 -
Deloitte Life Sciences & Thought Leadership
 The Deloitte Center For Health Solutions (“DCHS”) is Deloitte’s health services research arm, and seeks to inform 
healthcare clients about emerging trends, challenges, and opportunities using rigorous, up-to-date research.
 The Center employs a wealth of industry experts who author nationally acclaimed healthcare industry publications.
Bill Copeland
Bill Copeland is the U.S. Life Sciences 
and Healthcare Leader for Deloitte LLP 
and the sector leader of the practice's 
health plans group. A 26-year veteran 
with Deloitte, Bill has advised some of 
the organization's largest healthcare 
industry clients on their most strategic 
and transformative events, including 
mergers, affiliations, new business 
initiatives and financial and operational 
turnaround plans. He has also led 
projects around corporate governance 
and new management processes that 
link strategy to metrics and board 
oversight.
Vice Chairman
U.S. Life Sciences & 
Healthcare Leader
Deloitte LLP
Health Reform Memos
On a weekly basis, DCHS publishes the Monday Memo: Health Reform Update, which highlights news from 
the previous week on various healthcare reform efforts and implications for stakeholders. 
2013 Survey of U.S. Physicians: Perspectives about Healthcare Reform and the Future of 
the Medical Profession
The Deloitte 2013 Survey of U.S. Physicians presents key findings on physician perspectives about health 
care reform and the future of the medical profession. DCHS offers two reports: “2013 Survey of U.S. 
Physicians: Perspectives of health care reform and the future of the medical” and “Physician adoption of 
health information technology: Implications for medical practice leads and business partners.”
Breaking Constraints: Can Incentives Change Consumer Health Choices? 
Innovative incentive programs may well help individuals overcome the inertia that limits engagement in 
wellness programs, disrupting the trade-offs people make when pursuing healthcare goals. This issue brief 
explores factors driving employer interest in incentivizing participation in worksite wellness programs. 
What’s Around the Corner for the Health Care Industry 
Major elements of the ACA are scheduled to be implemented in 2013, including health insurance exchange 
(HIX) open enrollment, and new rates for small groups.  But healthcare cost containment will continue as a 
primary focus for the federal government, states, employers, and consumers.  This piece shares views on 
what developments industry stakeholders could expect within the next year and beyond. 
The Affordable Care Act of 2010: May 2013 Progress Report 
What are the major elements of the health reform law, the specific indicators of its progress, and the status of 
its implementation?  This tool was created by DCHS to engage clients interested in learning more about the 
major elements of the Affordable Care Act (ACA).  The report includes talking points and a suggested 
timetable to foster a dialogue with clients about the strategies necessary to survive in an ever-evolving, value-
driven, cost-containment environment. 
Survey Says Health Plans Advance Retail Capabilities: Highlights from Deloitte’s 2013 
Health Plan Retail Capability Survey
“Retail” is a hot topic in the health insurance industry today, and for good reason. From the creation of health 
insurance marketplaces, to the continued growth in Medicaid and Medicare, to the defined contribution 
movement and the rise of private exchanges, the sale and delivery of health insurance is requiring an 
increasing focus on the individual consumer. 
Leadership
Recent Publications
Leadership and Talent: Enabling Radical Cost Reduction through Effective 
Organizational Alignment
To remain competitive in the marketplace, healthcare providers must accommodate healthcare consumers, 
third party payors, and governmental regulators who increasingly demand higher quality treatment at lower 
costs. Additionally, recent and forthcoming regulations provide concrete incentives to minimize costs of 
treatment, such as lower Medicare and Medicaid reimbursement levels.
- 8 -
© 2015. For information, contact Deloitte Development LLC. 
Deloitte’s Connectivity Across the Healthcare Landscape
Deloitte’s cross-functional relationships and enormous reach throughout the healthcare industry routinely enhance DCF’s  
execution of M&A transactions because of our unique perspective and informed judgment.  
Physician Staffing
RCM Outsourcing
Hospitals
A Sample Of The Industry Leaders That We Work With…
- 9 -
© 2015. For information, contact Deloitte Development LLC. 
Deloitte Offers Leading HCIT Expertise
Deloitte Corporate Finance regularly leverages its access to one of the leading Healthcare IT consulting 
practices in the country accessing its network and expertise within the industry.
Deloitte has won several best in 
KLAS awards for revenue cycle and 
clinical transformation from KLAS, a 
leading healthcare IT vendor 
performance monitoring company. 
“Deloitte is the best consulting firm I have dealt with…
“Deloitte identified several millions of dollars of benefit that would be available to us.  That estimate ended up 
being even higher than what they initially projected, so it helped fund their work.”
“We picked Deloitte because they understand the mission of working with safety net providers.  They 
understand our mission, what we are trying to do, and the kinds of patients we are working with.”
- KLAS commentary
Deloitte has also received several 
accolades from Kennedy and Modern 
Healthcare.
“Deloitte brings deep and broad 
capabilities to healthcare clients; its 
balance of financial, technical, and 
industry consultants allows the firm 
to respond to more complex and 
comprehensive engagements.”
- 10 -
© 2015. For information, contact Deloitte Development LLC. 
Healthcare & Life Sciences Group Experience
Market Segment Focus
DCF’s Healthcare & Life Sciences Group combines extensive transactional experience, long-term client relationships, 
and in-depth industry knowledge to effectively advise our clients in today’s market environment.
Anesthesia Services
Contract Manufacturing
Contract Research Organization
Healthcare Clinics
Healthcare Information Technology
Healthcare Services
Hospitals
Laboratory Services
Managed Care/PBM
Medical Information Services
Medical Supplies & Distribution
Pharmacy
Physician Practice Management
Transcription, Billing, & Coding
Veterinary
Dave Vorhoff
Co-Head of Healthcare Group 
Prior Experience
- President, Managing Director, and head 
of healthcare group for McColl Partners.
- Managing Director for Banc of America 
Securities New York and NationsBanc
Montgomery Securities New York.
Ron Rivera
Co-Head of Technology Group 
Prior Experience
- Managing Director and head of   
technology group for McColl Partners.
- Various positions with SG Cowen 
Securities, Wachovia Securities, and 
SunTrust Robinson Humphrey.
- 11 -
© 2015. For information, contact Deloitte Development LLC. 
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
Select DCF Transaction in HCIT

Integrated Healthcare Solutions, Inc. (“IHS”) is a leading single-source provider of practice 
management solutions to healthcare providers nationwide.  

IHS offers electronic health records, enterprise practice management, revenue cycle  
management, interoperability/clinical data-sharing, and data center services.
 McColl Partners advised IHS on a mezzanine debt raise to launch several strategic growth 
initiatives.
 HealthSCOPE Benefits, Inc. (“HealthSCOPE”) is a leading provider of claims administration and 
health management services to self-funded employers throughout the United States.
 McColl Partners received multiple term sheets from various capital providers and assisted 
HealthSCOPE in choosing the optimal partner to suit the company’s needs.
 McColl Partners added significant value throughout the marketing process by properly 
positioning the company’s investment merits and creating a competitive process that resulted in 
terms that exceeded the clients’ expectations.
The undersigned acted as  
financial advisor to 
HealthSCOPE.*
has completed a recapitalization with
The undersigned acted as 
financial advisor to IHS.*
has completed a recapitalization with
Sale of Claims Administration Services Business
Debt Recapitalization Of Practice Management Software Vendor
 Vendor Credentialing Service ( “VCS”) is a rapidly growing healthcare information technology 
(“IT”) company that provides web-based vendor credentialing to hospitals and their vendor 
suppliers.
 McColl Partners identified untapped markets that could be exploited by VCS’s unique business 
model and highlighted all facets of the company’s product and service offering and unique 
business model to drive significant acquiror interest.
The undersigned acted as  
financial advisor for the transaction
has completed a recapitalization with
Sale of Vendor Credentialing Technology Company
- 12 -
© 2015. For information, contact Deloitte Development LLC. 
Select DCF Transaction in HCIT
 Project Racecar (“Racecar”) is the premier global provider of business process outsourcing 
solutions to healthcare organizations nationwide. 
 DCF is engaged to identify targets in the revenue cycle management and anesthesia billing / 
practice management industries.
 DCF has since identified more than 50 targets, two of which Racecar has entered advanced 
discussions and is negotiating definitive agreements.
 Project Gatsby (“Gatsby”) is a multi-specialty group practice with more than 2,000 physicians in 
over 100 medical and surgical specialties closely affiliated with a regional hospital network of 
more than 10 facilities.
 DCF has been engaged to advise Gatsby in evaluating and structuring a potential carve-out and 
sale of the group practice’s MSO.
Carve-out and Sale of Hospital-Based Physician MSO
Sale of Comprehensive RCM IT Solutions Provider
Acquisition Of Anesthesia Billing and Practice Management Companies
 Project Xenon (“Xenon”) is a leading provider of tech-enabled RCM solutions that span nearly the 
entire RCM spectrum, serving more than 7,000 physicians across the United States.
 Xenon’s proprietary technology platform boasts a sophisticated rules engine for claims 
documentation and filing.
 DCF has been engaged to assist Xenon in the evaluation of several strategic alternatives.
Project 
Xenon
The undersigned is acting 
as financial advisor to 
Project Xenon
Project 
Racecar
The undersigned is acting 
as financial advisor to 
Project Racecar
Project 
Gatsby
The undersigned is acting 
as financial advisor to 
Project Gatsby
- 13 -
© 2015. For information, contact Deloitte Development LLC. 
Select DCF Transaction in HCIT
 Project Lassie (“Lassie”) is a leading provider of back-end RCM solutions including: extended 
business office, self-pay and insurance, and bad debt collection services.
 Lassie has engaged DCF to identify the optimal operating and financial partner to support future 
growth.
Sale of Comprehensive EHR Software Provider 
Sale of Revenue Cycle Management Services Provider
 Project Rosetta (“Rosetta”) is a leading provider of open source EHR software built to improve 
efficiencies for clinical and administrative users in the U.S. government, VA hospital network, and 
commercial facilities.
 Rosetta has engaged DCF to assist the company in exploring strategic alternatives.
Project 
Rosetta
The undersigned is acting 
as financial advisor to 
Project Rosetta
Project 
Lassie
The undersigned is acting 
as financial advisor to 
Project Lassie
- 14 -
© 2015. For information, contact Deloitte Development LLC. 
Healthcare & Life Sciences Group Select Transactions
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
HCIT
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Vendor Credentialing Service, LLC.*
The undersigned acted as
financial advisor to
Integrated Healthcare Solutions, Inc.*
has completed a recapitalization with
has been acquired by
The undersigned acted as 
financial advisor to 
Fallon Community Health Plan.
The undersigned acted as 
financial advisor to 
FlexBen Corporation.*
has been acquired by
has acquired
The undersigned acted as 
financial advisor to 
Stryker Corporation.
The undersigned acted as 
financial advisor to 
Partners Rx Management, LLC.
has been acquired by
The undersigned acted as 
financial advisor to 
Career Step, LLC.*
has completed a management 
recapitalization with
The undersigned acted as financial 
advisor to etrials, Inc.*
has merged with
to form
etrials Worldwide, Inc.
The undersigned acted as 
financial advisor to 
HealthSCOPE.*
has completed a 
recapitalization with
has been acquired by
Coventry Health Care, Inc.
The undersigned acted as financial 
advisor to Altius Health Plans, Inc.*
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
ScriptSave.*
Outsourced Services
has completed a merger with
The undersigned acted as 
financial advisor to 
SRI/Surgical Express, Inc.*
The undersigned acted as 
financial advisor to 
TrustHouse Services Group, Inc.*
has been acquired by
The undersigned acted as 
financial advisor to 
TrustHouse Services Group, Inc.*
a portfolio company of
has acquired
The undersigned acted as
financial advisor to
KLMK Group, Inc..
has been acquired by
a portfolio company of
The undersigned acted as 
financial advisor to 
TrustHouse Services Group, Inc.*
has acquired
and its wholly owned subsidiary
The undersigned acted as 
financial advisor to 
TrustHouse Services Group, Inc.*
has acquired
The undersigned acted as 
financial advisor to 
TrustHouse Services Group, Inc.*
a portfolio company of
has acquired
has acquired
The undersigned acted as 
financial advisor to 
Stryker Corporation.
- 15 -
© 2015. For information, contact Deloitte Development LLC. 
Healthcare & Life Sciences Group Select Transactions (Cont’d) 
Home Health/Rehabilitation
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
Physician Practice Management
Dental Practice Management
The undersigned acted as 
financial advisor to Riverchase
Dermatology and Cosmetic Surgery.*
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Radiation Oncology Associates, PC 
and ROA Associates, LLP.
has entered into a partnership 
arrangement with
The undersigned acted as
financial advisor to MIRO/MCCI.
has been acquired by
The undersigned acted as 
financial advisor to 
Greater Houston Anesthesiology P.A.
a portfolio company of
has partnered with
Welsh, Carson, Anderson & 
Stowe
The undersigned acted as
financial advisor to Children’s 
Dentistry and Family Orthodontics.*
has completed a recapitalization with
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Kids Care Dental Group.*
has completed a recapitalization
The undersigned acted as 
financial advisor to 
Dentistry for Children, P.C.*
Hospitals
The undersigned acted as 
financial advisor to 
Columbia/HCA Healthcare Corp.
entered into a joint venture with
Columbia/HCA Healthcare 
Corporation
Hertzler Clinic, P.A.
The undersigned acted as 
financial advisor to 
Yale-New Haven Hospital.
has acquired
Quorom Health Group, Inc.
The undersigned acted as financial 
advisor to 
Northwest Health Systems, Inc.
has been acquired by
The undersigned acted as financial 
advisor to 
United Medical Corporation.
an affiliate of
has been acquired by
United Medical Corporation
The undersigned acted as 
financial advisor to 
United Medical Corporation
an affiliate of
has sold several behavioral hospitals 
and related assets to
United Medical Corporation
The undersigned acted as 
financial advisor Nebraska Heart Institute 
and Heart Hospital.
has acquired
The undersigned acted as 
financial advisor to 
Senior Select Home Health Services
and AHC Peronal Assisted Services
have been acquired by subsidiaries of
The undersigned acted as 
financial advisor to 
Healthtrax, Inc.*
William Blair Capital Partners
has completed a recapitalization with
has obtained for the acquisition of 
Therapy Management Services, Inc.
$29,000,000
Private Financing
The undersigned acted as financial 
advisor to EnduraCare, LLC.*
The undersigned acted as 
financial advisor to 
Premier Hospice & Palliative Care.
a portfolio company of
has acquired
have received an investment from
The undersigned acted as 
financial advisor to 
Accelerated Care Plus Corp.
- 16 -
© 2015. For information, contact Deloitte Development LLC. 
Healthcare & Life Sciences Group Select Transactions (Cont’d) 
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
Devices/Equipment
has been acquired by
The undersigned acted as 
financial advisor to 
Crown Therapeutics, Inc.
Crown Therapeutics, Inc.
Gateway HomeCare, Inc.
The undersigned acted as 
financial advisor to 
SP Industries, Inc.*
has been acquired by
has completed a merger with
The undersigned acted as 
financial advisor to 
SRI/Surgical Express, Inc.*
The undersigned acted as 
financial advisor to 
Delphi Medical Systems Corporation.*
has acquired
has been acquired by
The undersigned acted as 
financial advisor to 
Elastic Therapy, Inc.*
a portfolio company of
The undersigned acted as financial 
advisor to 
Burle Industries, Inc.*
has been acquired by
a portfolio company of
The undersigned acted as 
financial advisor to 
Home Health Medical Equipment, Inc. 
d/b/a AG Industries.*
has been acquired by
a portfolio company of
Madison Capital Partners
The undersigned acted as 
financial advisor to 
The Marena Group, Inc.*
has completed a recapitalization with
Distribution/Supplies
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
The SCOOTER Store, Ltd.*
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Woodbury Health Products.*
The undersigned acted as 
financial advisor to 
Meridian Healthcare Group.
has sold certain assets to
has been acquired by
The undersigned acted as 
financial advisor to 
NationsHealth, Inc.
Veterinary
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Diamondback Drugs, LLC.*
The undersigned acted as 
financial advisor to 
the Audit Committee of the Board of 
Directors of VCA Antech, Inc.
a subsidiary of
has acquired
has completed a 
management recapitalization with
The undersigned acted as 
financial advisor to 
Royal Pet Supplies, Inc.*
Quarry Capital Management
- 17 -
© 2015. For information, contact Deloitte Development LLC. 
Healthcare & Life Sciences Group Select Transactions (Cont’d) 
The undersigned acted as 
financial advisor to 
International Vitamin Corporation.
has acquired the
of
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
Pharmacy
Pharma/Contract Research
The undersigned acted as 
financial advisor to 
Zymed Laboratories Inc.*
has been acquired by
The undersigned acted as 
financial advisor to 
Diversified Pharmacy Group.*
has been acquired by
The undersigned acted as 
financial advisor to 
Cox Nuclear Pharmacies.*
has been acquired by
COX NUCLEAR
PHARMACIES
The undersigned acted as 
financial advisor to 
Coastal Pharmacy Services, Inc.*
has been acquired by
The undersigned acted as 
financial advisor to 
ITS Pharmacy, Inc.
a portfolio company of
has acquired
The undersigned acted as financial 
advisor to Medicap Pharmacies, Inc.
has been acquired by Management with 
financing provided by
Homeland Savings Bank, FSB
Senior Secured Facilities
and
Penninsula Capital Partners L.L.C.
Senior Subordinated Notes
Nutritional Supplements/
Nutraceuticals
The undersigned acted as 
financial advisor to 
Bio-Engineered Supplements & 
Nutrition, Inc.*
has been acquired by
The undersigned acted as 
financial advisor to the 
Special Committee of USANA.*
Nutritional Supplement 
Business
Fairness Opinion
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Diamondback Drugs, LLC.*
has acquired 
The undersigned acted as 
financial advisor to 
Altana, Inc.
Prescription Dermatology 
Product Portfolio of 
GlaxoSmithKline
The undersigned acted as 
financial advisor to 
Neways International.*
has been acquired by
The undersigned acted as 
financial advisor to 
Carolina Medical Products Company.*
received an investment from
Pharma Licensing, J.V., and Valuation
has entered into a partnership 
arrangement with 
The undersigned acted as 
financial advisor to 
BioMS Medical.
has entered into 
a joint venture with 
The undersigned acted as 
financial advisor to 
SemBioSys Genetics Inc.
has received
The undersigned acted as 
financial advisor to 
Resverlogix Corp.
Valuation Services
has entered into a strategic 
partnership with 
The undersigned acted as 
financial advisor to 
SemBioSys Genetics Inc.
and
- 18 -
© 2015. For information, contact Deloitte Development LLC.
Senior Debt
Private Capital Solutions Group
Subordinated Debt
Preferred Equity
> $6.0 Billion
 Specialized product experience with extensive lender and 
investor relationships.
 Regular dialogue with over 300 financing sources.
− International and U.S. commercial banks
− Finance companies
− Hedge funds 
− Business development corporations
− Mezzanine funds
 Ability to create competitive processes among potential 
lenders and investors.
 Reputation for innovative structures and completion of 
complex situations, including highly leveraged transactions 
and “challenged” credit deals.
DCF consistently has multiple engagements in the market and maintains regular dialogue with 
a large universe of capital providers that enables us to stay close to an ever-changing market.
DCF Advantage
Private Capital Solutions
- 19 -
© 2015. For information, contact Deloitte Development LLC. 
 DCF’s Financial Sponsors Group focuses on providing superior service and exceptional results through 
a high-touch, consistent coverage strategy with financial sponsors.
 The Financial Sponsors Group maintains dialogue with over 300 financial sponsors in a wide variety of 
markets throughout the United States and internationally.
 DCF has real-time information on which groups are interested in recapitalization transactions.
 Regular dialogue with these financial sponsors provides meaningful insight into the investment 
community’s interests in prospective acquisitions.
Financial Sponsors Group Select Transactions
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
American Importing Company, Inc.*
The undersigned acted as financial 
advisor to Dymatize Enterprises, Inc.*
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
Bailey International LLC.*
__________________
has completed a recapitalization with
The undersigned acted as 
financial advisor to 
KeyImpact Sales & Systems, Inc.*
__________________
has received a minority investment from
The undersigned acted as  
financial advisor to 
Vendor Credentialing Service, LLC.*.
__________________
has completed a recapitalization with
The undersigned acted as  
financial advisor to 
Carolina Medical Products Co.*
__________________
received an investment from
The undersigned acted as  
financial advisor to 
HealthSCOPE.*
_________________
has completed a recapitalization with
The undersigned acted as  
financial advisor to 
Royal Pet Supplies, Inc.*
a portfolio company of
a portfolio company of
has been acquired by
__________________
The undersigned acted as  
financial advisor to 
Kids Care Dental Group.*
has completed a recapitalization with
__________________
Financial Sponsors Group
*References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC.
The undersigned acted as  
financial advisor to 
ScriptSave.*
has completed a recapitalization with
The undersigned acted as  
financial advisor to 
Cardell Cabinetry.*
has completed a recapitalization with
The undersigned acted as  
financial advisor to 
Enhanced Recovery Corporation.*
has been acquired by
The undersigned acted as
financial advisor to 
Klein-Becker USA, LLC.*
a brand of
has been acquired by
The undersigned acted as 
financial advisor to the 
estate of the sole shareholder of 
Hooters of America, Inc.*
has been acquired by
A consortium of 
private equity investors
- 20 -
© 2015. For information, contact Deloitte Development LLC. 
Copyright © 2012 Deloitte Development LLC. All rights reserved.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, 
each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of 
Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of 
Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. 
Deloitte Corporate Finance LLC (“DCF”), member FINRA, is a wholly owned subsidiary of Deloitte Financial Advisory Services LLP (“Deloitte FAS”). 
Deloitte FAS is a subsidiary of Deloitte LLP. Investment banking products and services within the United States are offered exclusively through DCF.
Copyright © 2015 Deloitte Development LLC. All rights reserved.
Member of Deloitte Touche Tohmatsu Limited
</p>